$3.31 0.00 (%) IntelliPharmaCeutics International Inc - NASDAQ

May. 26, 2015 | 04:00 PM

Partner Headlines

  1. US Stock Futures Edge Lower Ahead Of Economic Data

    Benzinga | May. 26, 2015 | 07:08AM EST
  2. Intellipharmaceutics Says Final FDA Approval has Not Yet been Issued for 5 MG Strength of Generic Dexmethylphenidate Generic of Focalin XR

    Benzinga | May. 26, 2015 | 04:49AM EST
  3. Intellipharmaceutics to Acquire Real Property that Houses its Manufacturing, R&D and Office Facilities in Toronto, ON

    Benzinga | May. 26, 2015 | 04:47AM EST
  4. Morning Market Gainers

    Benzinga | May. 21, 2015 | 09:49AM EST
  5. Intellipharmaceutics Is 'Not Just A Generic Drug Story,' Brean Capital Says

    Benzinga | Feb. 23, 2015 | 16:56PM EST
  6. Analysts are Bullish on IntelliPharmaceuticals Following Deal with Teva Pharmaceuticals

    GuruFocus | Feb. 4, 2015 | 14:39PM EST
  7. Morning Market Gainers

    Benzinga | Feb. 2, 2015 | 09:44AM EST
  8. Top Performing Industries For October 23, 2014

    Benzinga | Oct. 23, 2014 | 10:31AM EST
  9. Intellipharmaceutics Reports Positive Results From A Series of Phase I Clinical Trials Of Regabatin XR

    Benzinga | Oct. 22, 2014 | 17:15PM EST
  10. Morning Market Losers

    Benzinga | Jul. 8, 2014 | 09:45AM EST
  11. Morning Market Movers

    Benzinga | Feb. 3, 2014 | 09:58AM EST
  12. Market Wrap For November 19: Home Depot's Strong Earnings Unable To Keep Dow In Positive Territory

    Benzinga | Nov. 19, 2013 | 16:34PM EST
  13. Intellipharmaceutics Announces Pricing of Public Offering of 1.5 Million Common Shares and Warrants

    Benzinga | Jul. 26, 2013 | 09:30AM EST
  14. Intellipharmaceutics Files Shelf Registration

    Benzinga | Jul. 26, 2013 | 05:54AM EST
  15. Health Care Sector Wrap

    FoxBusiness | Jul. 3, 2012 | 10:35AM EST
  16. Intellipharmaceutics to Raise US$5 Million at $2.75/Share Common Offering

    Benzinga | Mar. 9, 2012 | 02:13AM EST
Trading Center